Amyris, Inc.

Amyris, Inc.

Amyris, Inc.

Overview
Date Founded

2010

Headquarters

5885 HOLLIS STREET SUITE 100 EMERYVILLE CA 94608

Type of Company

Public

Employees (Worldwide)

503

Industries

Chemicals
Alternative Energy
Biotechnology

Company Description

Amyris is building an integrated renewable products company. Founded in 2003 and based in Emeryville, CA, Amyris is using breakthrough science and an innovative business model to address some of our planet’s most daunting problems. We first developed our technology under a non-profit initiative to provide a reliable and affordable source of artemisinin, a highly effective anti-malarial therapeutic. We are now applying our industrial synthetic biology platform to provide alternatives to a broad range of petroleum-sourced products. No Compromise® renewable fuels and chemicals are being designed to perform comparably to, or better than, the products they will replace. Amyris is establishing the partnerships and capabilities needed to bring our products to market as early as 2011, and to distribute these products directly to customers. Amyris subsidiaries include Amyris Brasil S.A., a majority-owned Brasilian company through which we conduct our Brasilian operations for the manufacture and trade of our products, and Amyris Fuels, LLC, a wholly-owned subsidiary through which we are building our U.S. fuels distribution capabilities

Contact Data
Trying to get in touch with decision makers at Amyris, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director, President & Chief Executive Officer

Chief Financial Officer

Chief Operating Officer

General Counsel & Secretary

Chief Business Officer

Chief People Officer

Chief Accounting Officer

President, Research & Development

President, Pipette

President of Biossance

Board of Directors

Board Member & Directors at Amyris, Inc.

Founder at 1-800-flowers.com, Inc.

Managing Partner at Vivo Capital LLC

Former Executive Vice President & Chief Financial Officer at Intuit, Inc.

Founder at NAXOS Capital Partners SCA

Director & Member of the Audit Committee at Black Hills Corp.

Former Executive Vice President & Head-Pharmaceutical Technical Operations at F. Hoffmann-La Roche Ltd.

Director, President & Chief Executive Officer at Amyris, Inc.

Former Partner at McKinsey & Co., Inc.

President & Chief Executive Officer at DSM Nutritional Products AG

Paths to Amyris, Inc.
Potential Connections via
Relationship Science
You
Amyris, Inc.
Owners & Shareholders
Details Hidden

Loyola Capital Management invests in undervalued financial services companies. The firm holds a concentrated portfolio of just 10-15 names and focuses on compelling valuations. Positions are selected by taking a long-term view, which often results in month-to-month volatility. Loyola shorts indices but not individual stocks. In addition to financials, Loyola also invests in energy and technology

Details Hidden

Vivo Ventures invests in US-based companies with therapeutic products in clinical development. The firm invests in the areas of biopharmaceuticals, specialty pharmaceuticals, medical devices, and other subsectors of healthcare and life sciences. Although they focus on companies with early-stage products, the firm is willing to work with companies that may not have significant infrastructure. They invest in companies with promising products at all financing stages and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

Details Hidden

Silverback Asset Management manages funds that that employ a convertible arbitrage strategy and funds that invest primarily in \"litigation finance\" companies.The firm's convertible arbitrage strategy seeks to capture returns from investments in credit, equity, volatility, and event-driven opportunities; but also may make investments in related strategies, including capital structure arbitrage and equity volatility arbitrage. Silverback actively manages exposures to equity, credit, volatility and interest rates, and may mitigate these risks via hedges where appropriate. To implement hedges and hedging strategies,the the firm engages in short selling and options trading and may utilize derivatives (e.g. credit default swaps), interest rate swaps, and futures and forward contracts.Silverback serves as investment manager to two private funds formed as partnerships which invest primarily in an emerging industry known as \"litigation finance.\" The strategy focuses on privately-negotiated investments in loans and private securities (specifically, asset-based high yield debt and equity); investments involving non-traditional and emerging asset financing techniques implemented through the combination of various privately negotiated investment agreements and vehicles; and investments in a non-diversified portfolio of illiquid and hard-to-value assets. The funds may employ the use of leverage.

Recent Transactions
Details Hidden

Amyris, Inc. raised money in a private placement transaction

Details Hidden

Amyris, Inc. raised money in a private placement transaction

Details Hidden

Amyris, Inc. raised money in a private placement transaction

Transaction Advisors
Legal Advisor

Advised onKoninklijke DSM NV, DSM Produtos Nutricionais Brasil SA purchase Amyris Brasil Ltda. from Amyris, Inc.

Underwriter

Advised onAmyris, Inc. issued . USD Common Stock

Escrow Agent

Advised onAmyris, Inc. issued . USD Common Stock

Attorney

Advised onAmyris, Inc. issued Common Stock

Legal Advisor

Advised onAmyris, Inc. issued Common Stock

Attorney

Advised onAmyris, Inc. issued Common Stock

Advisors & Consultants
Advisor

Founder at Calico LLC

Consultant

Director & Member of the Audit Committee at Black Hills Corp.

Legal Advisor

Partner at Fenwick & West LLP

Clients

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 23,500 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext.

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Taste, Scent, and Frutarom. The Taste segment is sold to the food and beverage industries for use in consumer products such as prepared foods, beverages, dairy, food, and sweet products. The Scent segment comprises of fragrance compounds, fragrance ingredients, and cosmetic active ingredients. The Frutarom segment creates and manufactures a naturals-focused suite of flavor compounds, functional foods and specialty fine ingredients, largely targeting small, local and regional customers. The company was founded in 1833 and is headquartered in New York, NY.

Sensient Technologies is the world's leading supplier of flavors, fragrances and colors used to make a diverse variety of foods and beverages, pharmaceuticals, cosmetics, home and personal care products, specialty printing and imaging products, computer imaging and industrial colors. To better reflect our expanded services and product capabilities, our Web site has been completely redesigned to serve as a more complete information resource for the many products and services we offer, as well as a resource for information about Sensient Technologies, its businesses, officers and financials. Our goal is not only to supply our customers with the highest-quality flavors, fragrances and colors available, but also to partner with our customers in creating world-class products

Key Stats and Financials As of 2018
Market Capitalization
$396M
Total Enterprise Value
$371M
Earnings Per Share
$-3.69
EBITDAMargin
-200.93%
Enterprise Value Sales
5.84x
Three Year Compounded Annual Growth Rate Of Revenue
23.03%
Debt TEV
0.57x
TEVNet Income
-1.61x
Five Year Compounded Annual Growth Rate Of Revenue
9.12%
Net Profit
$-230M
EBITDA
$-128M
Total Debt
$210M
Total Equity
$-212M
Revenue
$63.6M
Non-Profit Donations & Grants
$500 - $999
2015
$500 - $999
2011
$10K - $25K
2009
Investments
Details Hidden

Amyris Brasil SA produces renewable fuels and chemicals for energy, pharmaceutical and chemical applications. It provides its products for health, nutrition, personal care and industrial. The company was founded in 2008 and is headquartered in Campinas, Brazil.

Investors
Details Hidden

Kleiner Perkins Caufield & Byers (KPCB) focuses on investments in the life sciences, biodefense, green technology, information technology and companies with new technologies related to the iPhone and iPod touchpad platform.The firm's information technology investments focus on the consumer, enterprise, semiconductors, security and communications industries. They invest primarily in early-stage ventures that are incubating new companies with proven entrepreneurs and good ideas.KPCB's life sciences investments include medical devices, drugs, vaccines, personalized medicine, diagnostics and healthcare information technology and services. Their pandemic and biodefense investment initiative focuses on investments in companies with innovations in disease surveillance, rapid diagnostics, new vaccine technology, portable and less expensive manufacturing of vaccines and new antiviral drugs.The firm's iFund invests in market-changing ideas and products that extend the iPhone and iPod touch platform. The Fund invests across all sizes and stages. KPCB targets investments in companies that are developing applications, services and components. Their specific areas of interest include: location-based services, social networking, eCommerce (including advertising and payments), communication and entertainment.

Details Hidden

NIH is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions in every state across America and around the globe. NIH is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. NIH leadership plays an active role in shaping the agency's research planning, activities, and outlook. The Office of the Director is the central office at NIH, responsible for setting policy for NIH and for planning, managing, and coordinating the programs and activities of all the NIH components. The NIH Director, with a unique and critical perspective on the entire agency, is responsible for providing leadership to the Institutes and for constantly identifying needs and opportunities, especially for efforts that involve multiple Institutes. The NIH Director is assisted by the NIH Deputy Directors including the Principal Deputy Director, who shares in the overall direction of the agency's activities. NIH is responsive to Congressional legislation that adjusts NIH's programs to meet changing research needs. As a result of the NIH reauthorization process, NIH is able to respond strategically in an era when medical research requires constant innovation and increased interdisciplinary efforts. More than 80% of the NIH's budget goes to more than 300,000 research personnel at over 2,500 universities and research institutions. In addition, about 6,000 scientists work in NIH’s own Intramural Research laboratories, most of which are on the NIH main campus in Bethesda, Maryland. The main campus is also home to the NIH Clinical Center, the largest hospital in the world totally dedicated to clinical research. Successful biomedical research depends on the talent and dedication of the scientific workforce. NIH supports many innovative training programs and funding mechanisms that foster scientific creativity and exploration. The goal is to strengthen our nation’s research capacity, broaden our research base, and inspire a passion for science in current and future generations of researchers. NIH encourages and depends on public involvement in federally supported research and activities. NIH’s wide-ranging public efforts include outreach and education, nationwide events, requests for public input on NIH projects, and special programs designed specifically to involve public representatives in clinical research

Details Hidden

Founding General Partner at Khosla Ventures LLC

Suppliers
LVMH Beverages | Paris, IF

LVMH Moët Hennessy Louis Vuitton SE engages in the manufacture of luxury goods. It operates through the following business segments: Wines & Spirits, Fashion & Leather Goods, Perfumes & Cosmetics, Watches & Jewelry, Selective Retailing, and Other Activities & Eliminations. The Wines & Spirits segment produces and sells high quality champagne wines and sparkling wines. It also distributes vodka and white liquor. The Fashion & Leather Goods segment engages in the manufacture of luggage items, bags, accessories, shoes and clothes. The Perfumes & Cosmetics segment engages in the production and distribution of make-up, perfume and skin care products. The Watches & Jewelry segment manufactures luxury watches and accessories form men and women. It specializes in the field of chronographs and ultimate precision. The Selective Retailing segment is organized to promote an environment that is appropriate to the image and status of the luxury brands. It engages in the sale of luxury products to international travelers and on board cruise ships. This segment also manages beauty stores that combine direct access and customer assistance to customers. The Other Activities & Eliminations segment includes media division. It publishes newspapers and magazines, manages business and financial websites and holds radio stations. This segment also engages in the real estate industry and builds luxury yachts. The company was founded on January 1, 1987 and is headquartered in Paris, France.

ADL Bionatur Solutions SA Chemicals | Jerez de la Frontera, AN

ADL Bionatur Solutions SA operates as a biopharmaceutical company. It develops and produces active therapeutics substances. The company was founded in 2005 and is headquartered in Jerez de la Frontera, Spain.

Amazon.com, Inc. IT Consulting & Services | Seattle, Washington

Amazon.com, Inc. engages in the provision of online retail shopping services. It operates through the following business segments: North America, International, and Amazon Web Services (AWS). The North America segment includes retail sales of consumer products and subscriptions through North America-focused websites such as www.amazon.com and www.amazon.ca. The International segment offers retail sales of consumer products and subscriptions through internationally-focused websites. The Amazon Web Services segment involves in the global sales of compute, storage, database, and AWS service offerings for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Competitors
Colgate-Palmolive Co. Personal Products - New York, New York

Colgate-Palmolive Co. is engaged in the manufacturing and distribution of consumer products. It operates through Oral, Personal and Home Care; and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors. The Pet Nutrition segment offers pet nutrition products for dogs and cats. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

The Estée Lauder Companies, Inc. Personal Products - New York, NY

The Estée Lauder Companies, Inc. engages in the manufacturing of skin care, makeup, fragrance and hair care products. It sells products under the following brand names: Estée Lauder, Clinique, Origins, MžAžC, Bobbi Brown, La Mer, Jo Malone London, Aveda, and Too Faced. Its channels primarily consist of department stores, specialty multi-brand retailers, upscale perfumeries and pharmacies, and prestige salons and spas. The company was founded by Estée Lauder and Joseph Lauder in 1946 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Amyris, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Amyris, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Amyris, Inc..